The Valley Desk

NCT02113813 · Interventional trial

A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations

Overall registry status Completed

Phase 1

Conditions Epidermal Growth Factor Receptor Mutations, Non-Small-Cell Lung Cancer (NSCLC)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov